WCN26-4322 INTERMITTENT FEBUXOSTAT DOSING PROVIDES SUPERIOR RENOPROTECTION TO CONTINUOUS THERAPY IN PATIENTS WITH CKD (STAGES III-IV) AND HYPERURICEMIA

Read full text Summarise with VIRAT
Authors: Muhammad Zakir Hossain Khan, Fariha Tasnuva Dola, S M Ibne Shieakh
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Gout Hyperuricemia Uric Acid Chronic Kidney Disease and Diabetes Acute Kidney Injury Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104335–104335
Publication date
25 March 2026
Language
EN